Related Experiment Video
Updated: Oct 27, 2025

GC-based Detection of Aldononitrile Acetate Derivatized Glucosamine and Muramic Acid for Microbial Residue Determination in Soil
Published on: May 19, 2012
Investigation into Small Molecule Isomeric Glucuronide Metabolite Differentiation Using In Silico and Experimental
John R F B Connolly1, Jordi Munoz-Muriedas2, Cris Lapthorn3
1RCSI University of Medicine and Health Sciences, 123 St. Stephen's Green, Dublin D02 YN77, Ireland.
Ion mobility mass spectrometry (IMMS) shows promise for identifying drug metabolites, including isomers. While computational models correlate well with experimental data, distinguishing between isomers using collision cross-section values remains challenging.
Area of Science:
- Analytical Chemistry
- Computational Chemistry
- Pharmacology
Background:
- Identifying isomeric drug metabolites is complex, often requiring multiple analytical techniques like LC-MS and NMR.
- Ion mobility mass spectrometry (IMMS) offers a potential single-solution for rapid metabolite identification, including isomers.
- Automated computational pipelines comparing experimental and predicted collision cross-section (CCS) values can aid structural assignment.
Purpose of the Study:
- To evaluate the utility of IMMS combined with computational prediction for identifying isomeric drug metabolites.
- To compare the accuracy of quantum mechanics (QM) and machine learning (ML) models in predicting CCS values.
- To assess if the differences in CCS values between isomeric pairs are sufficient for unambiguous structural identification.
Main Methods:
- Utilized an ion mobility enabled Q-Tof mass spectrometer to measure CCS values for 28 small molecule glucuronide metabolites (14 isomeric pairs).
- Compared experimental CCS values against predictions from QM and ML *in silico* models.
- Analyzed the differences in CCS values between isomeric pairs to determine the potential for confident structural distinction.
Main Results:
- Both QM and ML models showed good correlation with experimental CCS values.
- QM and ML *in silico* methods produced similar predicted CCS values.
- The QM model better represented the CCS differences between isomers, though only naringenin glucuronides were confidently distinguished.
- The ML model could not confidently distinguish the studied isomer pairs.
Conclusions:
- IMMS coupled with *in silico* CCS prediction is a valuable tool for metabolite identification.
- While promising, current computational models, including QM and ML, have limitations in confidently distinguishing between all isomeric drug metabolites based solely on CCS differences.
- Further refinement of computational approaches and analysis of analyte structures are needed to improve the resolution of isomeric compounds.
More Related Videos
07:34Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Related Concept Videos
Drug Metabolism: Phase II Reactions
Phase II Reactions: Glucuronidation